July 15 (Reuters) - Atturra Ltd (ATA) :
- UNAUDITED FY24 REVENUE TO EXCEED A$240M, UP 35% ON PCP
- ATTURRA LTD SEES 20%+ GROWTH IN REVENUE FOR FY25 WHILST MAINTAINING UNDERLYING EBITDA OF 10.5%
- UNDERLYING EBITDA FOR FY OF A$25 MILLION TO A$26 MILLION, UP 19% ON PCP
(([email protected];))
- Forums
- ASX - By Stock
- ATA
- News: ATA Atturra Sees Unaudited FY24 Revenue To Exceed A$240 Mln, Up 35% On PCP
News: ATA Atturra Sees Unaudited FY24 Revenue To Exceed A$240 Mln, Up 35% On PCP
Featured News
Add ATA (ASX) to my watchlist
|
|||||
Last
81.0¢ |
Change
0.080(11.0%) |
Mkt cap ! $253.3M |
Open | High | Low | Value | Volume |
75.5¢ | 81.0¢ | 75.0¢ | $128.5K | 165.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 79.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
81.5¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.790 |
2 | 61754 | 0.780 |
3 | 2658 | 0.775 |
2 | 370 | 0.760 |
1 | 10000 | 0.755 |
Price($) | Vol. | No. |
---|---|---|
0.815 | 10000 | 1 |
0.820 | 12028 | 2 |
0.845 | 70000 | 1 |
0.850 | 22936 | 2 |
0.860 | 5000 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
ATA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online